The latest Market Talks covering Financial Services. Exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ...

Kenvue has a formidable lineup of well-known consumer health brands, such as Aveeno, Tylenol, Band-Aid, Zirtec, Listerine, ...

Kenvue (KVUE), a supplier of skin, healthcare, and beauty products, is a stock to consider buying. Starboard Value, an ...

JPMorgan analyst Andrea Teixeira keeps an Overweight rating on Kenvue (KVUE) after the Wall Street Journal reported Starboard Value has taken a ...

Sanofi will sell a 50% controlling stake in consumer healthcare unit Opella to private equity firm CD&R, with the French ...

Activist investor Starboard Value has a large stake in Kenvue (NYSE:KVUE), which spun out of Johnson & Johnson in mid-2023, according to people familiar with the matter. The activist is looking for ...

Here's what investors need to know today. 1. Boeing, Union Reach Tentative Deal To End Strike Boeing (BA) and the union ...

Headlines,Vest Financial LLC increases stake in Omnicom Group Inc.,Institutional investors dominate ownership of Omnicom ...

Headlines,Kenvue Declares Dividend of $0.205 Per Share,Projected Earnings Could Support Future Payouts,Short Payment History ...

The board of Kenvue Inc. ( NYSE:KVUE ) has announced that it will pay a dividend of $0.205 per share on the 27th ...

Kenvue (KVUE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PARIS (Reuters) -Sanofi has entered into talks to sell a controlling 50% stake in its consumer health business Opella to U.S.